-
TIME
Sunday, June 21, 2026
-
12:00 – 13:00
Registration
-
13:00 – 13:15
BFC Opening Remark - Cross-border Licensing Trends
Speaker:
David Chen, Managing Director, BFC Group
-
13:15 – 13:30
Keynote Speech #1 – Navigating BD Transactions with China's Biotechs and Pharmas
Speaker:
Josh Shin, Partner, Fangda Partners
-
13:30 – 13:45
Keynote Speech #1 – TBD
Speaker:
Dervis Pajo, US Tax Consulting Services Leader, China, PricewaterhouseCoopers
-
13:45 – 14:20
Fireside Chat: Perspectives from Senior Leaders at Global Pharma
Moderator:
David Chen, Managing Director and Founder, BFC Group
Speaker:
Wendy Cheung, Senior Vice President, TA Head of Oncology-Hematology, Global Pharma Strategy, Roche
-
14:20 – 14:30
Roadshow Company #1
-
14:30 – 14:40
Roadshow Company #2
-
14:40 – 15:30
Panel 1 – From Fast-follower to Innovation Engine: What are the Challenges and Opportunities for China Biotechs Going Global
Moderator:
Xiaoliang Sang, VP, Bioprocess, Cytiva China
Panelists:
Iva Morse, Vice President, Global Strategic Account, Cytiva Global
Jiayi Hao, VP, Head of Portfolio Strategy & Pipeline Operations, Pfizer Oncology, Pfizer
Qiusong Tang, Global Search & Evaluation Strategy Lead, Immunology, Infectious Diseases, Cardiovascular, Renal and Metabolic Diseases, Roche
-
15:30 – 15:40
Roadshow Company #3
-
15:40 – 15:50
Roadshow Company #4
-
15:50 – 16:40
Panel 2 – Biopharma Partnership Strategy: What’s Changing in 2026 and Beyond?
Moderator:
TBD
Panelists:
Scott DeWire, Corporate SVP and Head of Global BD&L, Boehringer Ingelheim
Adrianne Wong, Senior Director, S&E, Daiichi Sankyo
Fan Zhang, VP, Search and Evaluation, Business Development, Bristol Myers Squibb
Venky Raghavan, Executive Director Search & Evaluation – Oncology, Novartis
Andrew Wong, Head of Chugai Pharmaceutical Partnering, Chugai Pharmaceutical
-
16:40 – 16:50
Roadshow Company #5
-
16:50 – 17:00
Roadshow Company #6
-
17:00 – 17:50
Panel 3 – Capital Meets Innovation: Trends and Early Opportunities in Cross-Border Biotech Investing
Moderator:
TBD
Panelists:
Thomas G. Hopkins, Vice President and Global Head of ExploR&D, Eli Lilly
Jenny Yang, Head of Novo Nordisk External Innovation Asia Pacific, Novo Nordisk
Praveena Kandula, Partner, Aditum Bio
Nadim Shohdy, Chief Operating Officer, 3DC, Deerfield Management
Stephen Pitt, Global Head of R&D Search & Evaluation, CSL
-
17:50 – 18:30
Reception Session
